All lobbying filings

SPLITOAK STRATEGIES LLC

Lobbying for JOHNSON & JOHNSON SERVICES, INC. · Global biopharmaceutical, medical device and consumer product manufacturer.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 4

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act
HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
HR 1109
Litigation Transparency Act of 2025

Lobbying activity 2

Medicare/Medicaid

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT Act

Law Enforcement/Crime/Criminal Justice

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - the Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.